NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/14/2023
Back to search
Official data from USPTO
PALSAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
65
Latest update
11/14/2023
Trademark type
Word
Nice classes
1
Filing date
09/06/2019
Registration date
11/14/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2023
Last transaction
11/14/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
HERRERA-MARCUS, ROSELLE MORALDE
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SEKISUI MEDICAL CO., LTD.
Representatives
Boris Umansky LADAS & PARRY LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acid sequences as reagents for use in genetic researchother than for medical or veterinary purposes; nucleic acids for scientific purposeschemical compositions and materials in the nature of chemicals for use in genotypingall as chemicals for use in industry; reagentsenzymeschemical compositionschemical primers and chemical probes for use in the manufacture of pharmaceuticals; biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; nucleic acid sequences known as probes for use in signal amplification for use in the manufacture of diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in signal amplification techniques for use in the pharmaceutical industry; nucleic acid sequences known as probes for use in detecting nucleic acids for raw material in the manufacture of pharmaceuticals; nucleic acid sequences known as probes for use in detecting mRNA directly without synthesizing cDNA for use as a raw material in the manufacture of diagnostic reagents; nucleic acid sequences known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use as a raw material in the manufacture of diagnostic reagents for scientific or research use; nucleic acid sequences known as probes for use in forming self-assembly honeycomb structure for use as an ingredient in pharmaceuticals; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment for use as an ingredient in diagnostic reagents; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for an ingredient in diagnostic reagents for scientific or medical research; nucleic acid sequences known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for as diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in quantifying using samples from bloodtissue and cell lysates for use in cell cultures other than for medical or veterinary use; nucleic acid sequences known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for diagnostic reagents and preparationsexcept for medical or veterinary use; nucleic acid sequences known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in self-assembly reactions for as reagents for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes to be used as signal amplifier for use in industry to detect nucleic acids; nucleic acid sequences known as probes for use in analyzing samples without using PCR for use in industry to detect mRNAs; biochemical reagents commonly known as probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying using samples from bloodtissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembly formed by a short DNA probe pair for use in industry utilizing technology of DNA self-assembly reactions
Publications
History of USPTO decisions and trademark events.
65 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/12/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/28/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/28/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2022
ALIE
ASSIGNED TO LIE
10/25/2022
ALIE
ASSIGNED TO LIE
09/19/2022
ALIE
ASSIGNED TO LIE
09/14/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/31/2022
GNSL
LETTER OF SUSPENSION E-MAILED
03/31/2022
CNSL
SUSPENSION LETTER WRITTEN
03/31/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/21/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/21/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/10/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/13/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/10/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/10/2021
CNSI
SUSPENSION INQUIRY WRITTEN
09/10/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/04/2021
GNSL
LETTER OF SUSPENSION E-MAILED
02/04/2021
CNSL
SUSPENSION LETTER WRITTEN
02/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/03/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/03/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/03/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/04/2020
GNRT
NON-FINAL ACTION E-MAILED
08/04/2020
CNRT
NON-FINAL ACTION WRITTEN
08/04/2020
DPCC
DIVISIONAL PROCESSING COMPLETE
07/16/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/24/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/24/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/24/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/24/2020
ALIE
ASSIGNED TO LIE
06/16/2020
DRRR
DIVISIONAL REQUEST RECEIVED
06/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/08/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/28/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/06/2019
GNRT
NON-FINAL ACTION E-MAILED
12/06/2019
CNRT
NON-FINAL ACTION WRITTEN
12/06/2019
DOCK
ASSIGNED TO EXAMINER
11/23/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2019
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
09/11/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/11/2019
NWAP
NEW APPLICATION ENTERED
09/10/2019
Continuous trademark protection
Get notified about every new filing that threatens PALSAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.